Anavex Life Sciences
AVXL
AVXL
141 hedge funds and large institutions have $232M invested in Anavex Life Sciences in 2023 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 42 increasing their positions, 40 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.14% more ownership
Funds ownership: 34.61% → 34.74% (+0.14%)
7% less capital invested
Capital invested by funds: $249M → $232M (-$17.2M)
Holders
141
Holding in Top 10
–
Calls
$15.9M
Puts
$9.03M
Top Buyers
| 1 | +$4.7M | |
| 2 | +$2.83M | |
| 3 | +$2M | |
| 4 |
Barclays
London,
United Kingdom
|
+$1.54M |
| 5 |
Citigroup
New York
|
+$1.43M |
Top Sellers
| 1 | -$6.47M | |
| 2 | -$2.6M | |
| 3 | -$1.64M | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$1.17M |
| 5 |
State Street
Boston,
Massachusetts
|
-$1.16M |